HUREL Models Assist in the Evaluation of Hepatoxicity
Many drug candidates fail during clinical trials and post-market withdrawal due to hepatoxicity or Drug Induced Liver Injury (DILI). [...]
HUREL Model Micro Livers and Hepatitis B
While hepatitis B infection is preventable by a well-established vaccine, the disease has proven to be [...]
Improved Prediction of Hepatotoxicity (or DILI) Using HUREL® Hepatic Co-cultures
Mike Johnson2021-10-14T13:24:22-05:00Hepatotoxicity (liver cell toxicity) is one of the major causes of drug attrition during clinical development and withdrawal post-marketing. [...]
Making Precision Cut Tissue Slices Webinar
'Making Precision Cut Tissue Slices for Ex Vivo Assay Services' webinar was given in partnership with Precisionary Instruments. [...]
HALO® Image Analysis Platform Added to Visikol’s Digital Pathology Services
Visikol understands that modern medicine requires detailed understanding not only of the disease but of the body’s response to [...]
2021 BICO PARTNERSHIP CONFERENCE
Join us virtually for an exciting 2-day conference bringing together industry experts and key opinion leaders [...]
Visikol Continues to Expand Imaging Capabilities with an Additional High-Content Confocal Imager
Visikol has added an additional ImageXpress® Micro Confocal High-Content Imaging System from Molecular Devices to its robust imaging capabilities [...]
Visikol Expands its Automation Capabilities Through Adding the C.WASH from Cytena
In its efforts to expand and improve the many cell culture assays and in vitro studies offered, Visikol has [...]
BICO FOR LIFE 2021
Over the weekend the Visikol team and their families joined the rest of the BICO family in participating in [...]
Colocalization of Two Labels Using ImageJ
A frequent image analysis technique that is performed routinely at Visikol is the colocalization of many different biological labels [...]